Publication:
Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study

Loading...
Thumbnail Image
Date
2020-05-01T00:00:00Z
Authors
Bulut, Esra Ates
Alak, Zehra Yagmur Sahin
Dokuzlar, Ozge
Kocyigit, Suleyman Emre
SOYSAL, PINAR
Smith, Lee
IŞIK, AHMET TURAN
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Aims: Type 2 Diabetes Mellitus(DM) is a well-known risk factor for cognitive impairment. Recent evidences suggest that Dipeptidyl peptidase-4(DPP-4) inhibitors might have neuroprotective effects. Therefore, this study aimed to investigate vildagliptin, a DPP-4 inhibitor, effects on cognitive function in older patients with DM.
Description
Keywords
Citation
Bulut E. A. , Alak Z. Y. S. , Dokuzlar O., Kocyigit S. E. , SOYSAL P., Smith L., IŞIK A. T. , -Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study-, ARCHIVES OF GERONTOLOGY AND GERIATRICS, cilt.88, 2020
Page Views

0

File Downloads

9

Sustainable Development Goals